首站-论文投稿智能助手
典型文献
Long-term outcome of percutaneous or surgical revascula-rization with and without prior stroke in patients with three-vessel disease
文献摘要:
OBJECTIVE To determine whether high-risk patients with three-vessel disease (TVD) with and without prior stroke preferen-tially benefit from three strategies [percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG) and medical therapy (MT)].METHODS A total of 8943 patients with TVD were included in the study. Patients enrolled were stratified into two categories according to the presence or absence of prior stroke history. The primary endpoint was all-cause death. Secondary endpoints in-cluded stroke and major adverse cardiac and cerebrovascular event (MACCE), a composite of death, myocardial infarction (MI), unplanned revascularization and stroke. RESULTS Prior stroke was present in 888 patients (9.9%). These patients were older and had higher rates of comorbidities. Du-ring a median follow-up of 7.5 years, patients with prior stroke were strongly associated with increased risks of all-cause death, cardiac death, stroke and MACCE, even after adjusting for confounding variables and results been consistent across either treat-ment subgroup (PCI, CABG and MT) (all adjusted P < 0.01). Notably, there was a significant interaction between prior stroke his-tory and treatment strategies. Revascularization strategy (PCI or CABG) was associated with a lower incidence of all-cause death and MACCE compared with MT alone, and favorable rates of MACCE, MI and unplanned revascularization in the CABG group compared with the PCI group, but with similar rate of all-cause death regardless of prior stroke history. The prevalence of stroke was significantly higher after CABG when compared with PCI or MT in no prior stroke patients [hazard ratio (HR) = 1.429, 95% CI:1.132–1.805 for CABG vs. MT; HR = 1.703, 95% CI: 1.371–2.116 for CABG vs. PCI]. CONCLUSIONS Patients with TVD and prior stroke have poor clinical outcomes. It is essential to balance benefit and risk when determining the optimal treatment strategy for TVD with and without prior stroke.
文献关键词:
作者姓名:
Na XU;Ce ZHANG;Lin JIANG;Jing-Jing XU;Ru LIU;Ying SONG;Xue-Yan ZHAO;Lian-Jun XU;Run-Lin GAO;Bo XU;Jin-Qing YUAN;Lei SONG
作者机构:
Center for Coronary Heart Disease,National Clinical Research Center for Cardiovascular Diseases,National Center for Cardiovascular Diseases,State Key Laboratory of Cardiovascular Disease,Fuwai Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing,China
引用格式:
[1]Na XU;Ce ZHANG;Lin JIANG;Jing-Jing XU;Ru LIU;Ying SONG;Xue-Yan ZHAO;Lian-Jun XU;Run-Lin GAO;Bo XU;Jin-Qing YUAN;Lei SONG-.Long-term outcome of percutaneous or surgical revascula-rization with and without prior stroke in patients with three-vessel disease)[J].老年心脏病学杂志(英文版),2022(08):583-593
A类:
revascula,rization,preferen
B类:
Long,percutaneous,surgical,without,prior,stroke,patients,three,vessel,disease,OBJECTIVE,To,determine,whether,TVD,tially,benefit,from,strategies,coronary,intervention,PCI,artery,bypass,grafting,CABG,medical,therapy,MT,METHODS,total,were,included,study,Patients,enrolled,stratified,into,two,categories,according,presence,absence,history,primary,was,cause,death,Secondary,endpoints,major,adverse,cardiac,cerebrovascular,event,MACCE,composite,myocardial,infarction,MI,unplanned,revascularization,RESULTS,Prior,present,These,older,had,higher,rates,comorbidities,Du,ring,median,follow,years,strongly,associated,increased,risks,after,adjusting,confounding,variables,results,been,consistent,across,either,subgroup,adjusted,Notably,there,interaction,between,treatment,Revascularization,strategy,lower,incidence,compared,alone,favorable,but,similar,regardless,prevalence,significantly,when,no,hazard,ratio,CONCLUSIONS,have,poor,clinical,outcomes,It,essential,balance,determining,optimal
AB值:
0.461349
相似文献
Treatment outcomes of HIV patients with hepatitis B and C virus co-infections in Southwest China: an observational cohort study
Jia Jingya;Zhu Qiuying;Deng Luojia;Lan Guanghua;Johnson Andrew;Chen Huanhuan;Shen Zhiyong;Li Jianjun;Xing Hui;Ruan Yuhua;Li Jing;Lu Hui;Vermund Sten H.;Zhu Jinhui;Qian Han-Zhu-SJTU-Yale Joint Center for Biostatistics and Data Science, Shanghai Jiao Tong University, Shanghai, China;Department of Bioinformatics and Biostatistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China;Guangxi Key Laboratory of Major Infectious Disease Prevention Control and Biosafety Emergency Response, Guangxi Center for Disease Control and Prevention, Nanning, China;Groton School, Groton, MA, USA;State Key Laboratory of Infectious Disease Prevention and Control (SKLID), Chinese Center for Disease Control and Prevention (China CDC), Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, China;School of Public Health, Yale University, New Haven, CT, USA
Multimorbidity patterns and association with mortality in 0.5 million Chinese adults
Fan Junning;Sun Zhijia;Yu Canqing;Guo Yu;Pei Pei;Yang Ling;Chen Yiping;Du Huaidong;Sun Dianjianyi;Pang Yuanjie;Zhang Jun;Gilbert Simon;Avery Daniel;Chen Junshi;Chen Zhengming;Lyu Jun;Li Liming-Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China;Peking University Center for Public Health and Epidemic Preparedness and Response, Peking University, Beijing 100191, China;National Clinical Research Center of Cardiovascular Diseases, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China;China Kadoorie Biobank National Coordination Centre, Chinese Academy of Medical Sciences, Beijing 100730, China;Nuffield Department of Population Health, Medical Research Council Population Health Research Unit, University of Oxford, Oxford OX3 7LF, United Kingdom;Nuffield Department of Population Health, University of Oxford, Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Oxford OX3 7LF, United Kingdom;Suzhou Center for Disease Control and Prevention, Suzhou, Jiangsu 215004, China;China National Center for Food Safety Risk Assessment, Beijing 100022, China;Key Laboratory of Molecular Cardiovascular Sciences, Peking University, Ministry of Education, Beijing 100191, China
A trial of arbidol hydrochloride in adults with COVID-19
Zhao Jingya;Zhang Jinnong;Jin Yang;Tang Zhouping;Hu Ke;Sun Hui;Shi Mengmeng;Yang Qingyuan;Gu Peiyu;Guo Hongrong;Li Qi;Zhang Haiying;Li Chenghong;Yang Ming;Xiong Nian;Dong Xuan;Xu Juanjuan;Lin Fan;Wang Tao;Yang Chao;Huang Bo;Zhang Jingyi;Chen Shi;He Qiong;Zhou Min;Qu Jieming-Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China;Institute of Respiratory Diseases, School of Medicine, Shanghai Jiao Tong University, Shanghai 200025, China;Department of Emergency, Union Medical College Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430058, China;Department of Respiratory and Critical Care Medicine, Union Medical College Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430058, China;Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China;Department of Respiratory and Critical Care Medicine, Renmin Hospital, Wuhan University, Wuhan, Hubei 430060, China;Department of Endocrinology, Union Medical College Affiliated to Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430058, China;Department of Respiratory Medicine, Wuhan Bauhinia Hospital, Wuhan, Hubei 430062, China;Department of Respiratory Medicine, Guanggu Hospital District, The Third Hospital of Wuhan, Wuhan, Hubei 430074, China;Department of Respiratory and Critical Care Medicine, Puren Hospital, Wuhan University of Science and Technology, Wuhan, Hubei 430081, China;Department of Respiratory Medicine, The Third People’s Hospital of Hubei Province, Wuhan, Hubei 430030, China;Department of Respiratory Medicine, The Sixth General Hospital of Hubei Province, Wuhan, Hubei 430015, China;Tuberculosis Department of Chengdu Public Health Clinical Medical Center, Chengdu, Sichuan 610066, China;Department of Neurology, Wuhan Red Cross Hospital, Wuhan, Hubei 430015, China;Department of Tuberculosis, Jinyintan Hospital, Wuhan, Hubei 430048, China;Department of Cardiology, The Third People’s Hospital of Hubei Province, Wuhan, Hubei 430030, China
Dynamic changes of renal cortical blood perfusion before and after percutaneous transluminal renal artery stenting in patients with severe atherosclerotic renal artery stenosis
Ma Na;Li Yan;Wang Siyu;Li Mengpu;Li Yongjun;Ai Hu;Zhu Hui;Wang Yang;Guo Fajin;Ren Junhong-Department of Sonography, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing 100730, China;Department of Vascular Surgery, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing 100730, China;Department of Cardiology, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing 100730, China;Department of Nuclear Medicine, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing 100730, China;Department of Medical Research & Biometrics Center, National Center for Cardiovascular Diseases and Fuwai Hospital, CAMS and PUMC, Beijing 100037, China
Chinese registry of rheumatoid arthritis (CREDIT) V: sex impacts rheumatoid arthritis in Chinese patients
Jiang Nan;Li Qin;Li Hongbin;Fang Yongfei;Wu Lijun;Duan Xinwang;Xu Jian;Zhao Cheng;Jiang Zhenyu;Wang Yanhong;Wang Qian;Leng Xiaomei;Li Mengtao;Tian Xinping;Zeng Xiaofeng;CREDIT Co-Authors-Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences and Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science and Technology; State Key Laboratory of Complex Severe and Rare Diseases; Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China;Department of Rheumatology, the First People’s Hospital of Yunnan Province, Kunming, Yunnan 650032, China;Department of Rheumatology, the Affiliated Hospital of Inner Mongolia Medical College, Hohhot, Inner Mongolia 010050, China;Department of Rheumatology, Southwest Hospital, Third Military Medical University, Chongqing 400038, China;Department of Rheumatology and Immunology, People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang 830001, China;Department of Rheumatology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330006, China;Department of Rheumatology and Immunology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650032, China;Department of Rheumatology, The First Affiliated Hospital of Guangxi Medical University, Manning, Guangxi 530021, China;Department of Rheumatology, The First Hospital of Jilin University, Changchun, Jilin 130021, China;Department of Epidemiology and Bio-Statistics, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing 100005, China
Feasibility and Surgical Effect of Annulus Sparing in Consecutive Patients with Tetralogy of Fallot: A Retrospective Cohort Study
Lv Lizhi;Liu Jinyang;Jiang Xianchao;Liu Yang;Tian Yanjin;Cao Hong;Liu Zhimin;Wang Qiang-Center for Pediatric Cardiac Surgery, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China;Echocardiography Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China;Arrhythmia, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China;Department of Cardiac Surgery, Yunnan Fuwai Cardiovascular Hospital, Kunming 650102, China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。